These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8385896)

  • 21. Effect of acyclovir on the deoxyribonucleoside triphosphate pool levels in Vero cells infected with herpes simplex virus type 1.
    Furman PA; Lambe CU; Nelson DJ
    Am J Med; 1982 Jul; 73(1A):14-7. PubMed ID: 6285704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
    Spector T; Harrington JA; Morrison RW; Lambe CU; Nelson DJ; Averett DR; Biron K; Furman PA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1051-5. PubMed ID: 2536930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of flavonoids and acyclovir against herpesviruses in cell cultures.
    Mucsi I; Gyulai Z; Béládi I
    Acta Microbiol Hung; 1992; 39(2):137-47. PubMed ID: 1339152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    Levin MJ; Weinberg A; Leary JJ; Sarisky RT
    Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of combined inhibitors of thymidylate synthase-5-fluorodeoxyuridine and quinazoline antifolates on murine leukemia cells cultured in vitro.
    Balinska M; Szablewska I; Janiszewska D; Brzezinska A; Pawelczak K
    Anticancer Res; 1997; 17(6D):4519-24. PubMed ID: 9494561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
    Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleoside metabolism in herpes simplex virus-infected cells following treatment with interferon and acyclovir, a possible mechanism of synergistic antiviral activity.
    O'Brien WJ; Coe EC; Taylor JL
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1178-82. PubMed ID: 2393279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation.
    Faessel HM; Slocum HK; Jackson RC; Boritzki TJ; Rustum YM; Nair MG; Greco WR
    Cancer Res; 1998 Jul; 58(14):3036-50. PubMed ID: 9679969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interconversion of tetrahydrofolate cofactors to dihydrofolate induced by trimetrexate after suppression of thymidylate synthase by fluorodeoxyuridine in L1210 leukemia cells.
    Seither RL; Rape TJ; Goldman ID
    Biochem Pharmacol; 1992 Jun; 43(12):2647-54. PubMed ID: 1385949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
    Yamada Y; Yamamoto N; Daikoku T; Nishiyama Y
    Microbiol Immunol; 1991; 35(8):681-6. PubMed ID: 1661366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
    Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
    Eppstein DA; Marsh YV
    Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
    Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
    Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance.
    Fantz CR; Shaw D; Moore JG; Spencer HT
    Biochem Biophys Res Commun; 1998 Feb; 243(1):6-12. PubMed ID: 9473470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
    Daikoku T; Shiraki K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
    [No Abstract]   [Full Text] [Related]  

  • 40. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.